<DOC>
<DOCNO>EP-0646595</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Nucleic acid binding oligomers having C-branches for therapy and diagnosis
</INVENTION-TITLE>
<CLASSIFICATIONS>C07D40312	C07D47330	C07D23900	A61K3800	C07K506	A61K31185	C07K1400	C07K5062	A61K31401	C07D40306	C07D47318	A61K3140	C07K500	A61K31401	C07K1400	A61P3112	C07K1900	C07K1900	A61K3140	C07D47300	C07K700	C07D40300	C07D23954	A61K31195	A61K3800	A61P3100	C07K706	C07D23947	C07D47334	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07D	C07D	C07D	A61K	C07K	A61K	C07K	C07K	A61K	C07D	C07D	A61K	C07K	A61K	C07K	A61P	C07K	C07K	A61K	C07D	C07K	C07D	C07D	A61K	A61K	A61P	C07K	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07D403	C07D473	C07D239	A61K38	C07K5	A61K31	C07K14	C07K5	A61K31	C07D403	C07D473	A61K31	C07K5	A61K31	C07K14	A61P31	C07K19	C07K19	A61K31	C07D473	C07K7	C07D403	C07D239	A61K31	A61K38	A61P31	C07K7	C07D239	C07D473	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to nucleic acid-binding oligomers with N branching of the general formula (I) 
<
IMAGE
>
 and the monomers thereof, where the individual radicals have the meaning stated in the description, to the use thereof as pharmaceuticals or as diagnostic aids.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
Compounds of the general formula (I),


in which

A
represents -(CH
2
)
n
- or -CO-,
B
represents all natural or unnatural nucleobases,
such as, for example, thymine, uracil, cytosine,

adenine, guanine or hypoxanthine, or derivatives
derived therefrom by chemical modification, or

halogenated precursors thereof, optionally substituted
on the amino groups by protective groups

such as acetyl, trifluoroacetyl, trichloroacetyl,
benzoyl, phenylacetyl, benzyloxycarbonyl, tert-butyloxycarbonyl,

allyloxycarbonyl or (9-fluorenyl)methoxycarbonyl,
or other protective groups

which are customary in peptide and nucleic acid
chemistry, or possessing free amino groups, 
D
represents -(CO)
p
-,
E and G,
independently of each other, represent
-CHR-, where
R
represents H or a residue of a natural or unnatural
amino acid, e.g. from glycine, alanine,

valine, leucine, isoleucine, serine, threonine,
cysteine, methionine, phenylalanine, tyrosine,

histidine, tryptophan, lysine, ornithine, asparagine,
aspartic acid, glutamine, glutamic acid,

arginine, proline, hydroxyproline or sarcosine,
dehydroamino acids, such as, for example, dehydroalanine

or dehydro-α-aminobutyric acid,
other unnatural amino acids, such as

phenylglycine, 4-nitrophenylalanine,
3-nitrophenylalanine, 2-nitrophenylalanine, 2-,

3 - or 4-aminophenylalanine,
3,4-dichlorophenylalanine, 4-iodophenylalanine,

4-methoxyphenylalanine, 1-triazolylalanine,
2-pyridylalanine, 3-pyridylalanine,

4-pyridylalanine, 1-naphthylalanine or 2-naphthylalanine,
optionally possessing protective

groups, in their D or L form, or, optionally,
E and G
are linked together via an alkyl chain
-(CH
2
)
q
-,
K
represents -CO-, -SO
2
- or -CH
2
-,
L
can be a carrier system, reporter ligand, a
solubility-mediating group or hydrogen,
M
can, independently of L, be a carrier system,
reporter ligand, a solubility-mediating group or

hydrogen,
m
can be 0, 1, 2 or 3, 
n
can be 0, 1, 2, 3 or 4,
p
can be 0, 1 or 2,
q
can be 0, 1 or 2, and
s
can assume values of between 1 and 30.
Compounds of the general formula (I) according to
Claim 1

in which

A
represents -(CH
2
)
n
- or -CO-,
B
represents all natural nucleobases, such as, for
example, thymine, uracil, cytosine, adenine,

guanine or hypoxanthine, or halogenated precursors
thereof, optionally substituted on the

amino groups by protective groups such as acetyl,
trifluoroacetyl, trichloroacetyl, benzoyl, phenylacetyl,

benzyloxycarbonyl, tert-butyloxycarbonyl,
allyloxycarbonyl or

(9-fluorenyl)methoxycarbonyl, or other protective
groups which are customary in peptide and nucleic

acid chemistry, or possessing free amino groups,
D
represents -(CO)
p
-,
E and G,
independently of each other, represent
-CHR-, where
R
represents H or a residue of a natural or unnatural
amino acid, e.g. from glycine, alanine,

valine, leucine, isoleucine, serine, threonine,
cysteine, methionine, phenylalanine, tyrosine,

histidine, tryptophan, lysine, ornithine, asparagine,
aspartic acid, glutamine, glutamic acid, 

arginine, proline, hydroxyproline or sarcosine,
dehydroamino acids, such as, for example,

dehydroalanine or dehydro-α-aminobutyric acid,
other unnatural amino acids, such as

phenylglycine, 2-pyridylalanine,
3-pyridylalanine, 4-pyridylalanine,

1-naphthylalanine or 2-naphthylalanine, optionally
possessing protective groups, in their D or

L form, or, optionally,
E and G
are linked together via an alkyl chain
-(CH
2
)
q
-,
K
can be -CO-, -SO
2
- or -CH
2
-,
L
can be a carrier system, reporter ligand, a
solubility-mediating group or hydrogen,
M
can, independently of L, be a carrier system,
reporter ligand, a solubility-mediating group or

hydrogen,
m
can be 0, 1, 2 or 3,
n
can be 0, 1, 2 or 3,
p
can be 0 or 1,
q
can be 0, 1 or 2, and
s
can assume values of between 3 and 20.
Compounds of the general formula (I) according to
Claim 1

in which

A
represents -(CH
2
)
n
- or -CO-, 
B
represents all natural nucleobases, such as, for
example, thymine, uracil, cytosine, adenine,

guanine or hypoxanthine, or halogenated precursors
thereof, optionally substituted on the

amino groups by protective groups such as acetyl,
trifluoroacetyl, trichloroacetyl, benzoyl, phenylacetyl,

benzyloxycarbonyl, tert-butyloxycarbonyl,
allyloxycarbonyl or (9-fluorenyl)methoxycarbonyl,

or other protective groups which
are customary in peptide and nucleic acid chemistry,

or possessing free amino groups,
D
represents -(CO)
p
-,
E and G,
independently of each other, represent
-CHR-, where
R
represents H or a residue of a natural or
unnatural amino acid, for example from glycine,

alanine, valine, leucine, isoleucine, serine,
threonine, cysteine, methionine, phenylalanine,

tyrosine, histidine, tryptophan, lysine,
ornithine, asparagine, aspartic acid, glutamine,

glutamic acid, arginine, proline, hydroxyproline
or sarcosine, or dehydroamino acids, such as, for

example, dehydroalanine or dehydro-α-aminobutyric
acid, optionally possessing protective groups, in

their D or L form, or, optionally,
E and G
are linked together via an alkyl chain
-(CH
2
)
q
-,
K
is -CO-,
L
can be a carrier system, reporter ligand, a
solubility-mediating group or hydrogen,
M
can, independently of L, be a carrier system, 
reporter ligand, a solubility-mediating group or

hydrogen,
m
can be 0, 1 or 2,
n
can be 0, 1, 2 or 3,
p
can be 0 or 1,
q
can be 0 or 1, and
s
can assume values of between 3 and 18.
Medicament containing one or more compounds from the
Claims 1 to 3.
Use of compounds according to Claims 1 to 3 for
preparing medicaments.
</CLAIMS>
</TEXT>
</DOC>
